Abstract
Variation in the DNA profile and antifungal susceptibility of 271 bloodstream isolates of Candida species was evaluated. The isolates were obtained from 152 nonneutropenic patients hospitalized in 21 different medical centers. In general, each patient was infected with their own distinct DNA type of Candida, and in those cases in which multiple cultures were positive, the same strain was isolated repeatedly over time. Minimum inhibitory concentrations of fluconazole or amphotericin B did not increase over time among the strains isolated repeatedly from individual patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
